CSIMarket
 


Revolution Medicines Inc   (RVMD)
Other Ticker:  
 

Revolution Medicines Inc Profitability Comparisons

Select each Category to receive further Information


RVMD Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q3 MRQ) - 60.34 % 48.45 % 45.99 %
Gross Margin (Q3 TTM) - 62.39 % 49.56 % 45.56 %
Gross Margin 5 Yr. Avg. - 67.93 % 50.34 % 47.7 %
EBITDA Margin (Q3 MRQ) -2156.38 % 16.71 % 12.1 % 17.85 %
EBITDA Margin (Q3 TTM) -814.86 % 9.98 % 12.58 % 18.7 %
EBITDA Margin 5 Yr. Avg. - 29.88 % 15.52 % 37.84 %
Operating Margin (Q3 MRQ) -2280.48 % 12.21 % 8.44 % 14.96 %
Operating Margin (Q3 TTM) -845.42 % 11.74 % 10.02 % 15.73 %
Operating Margin 5 Yr. Avg. - 18.9 % 10.68 % 14.62 %
Pre-Tax Margin (Q3 MRQ) -2193.86 % 9.26 % 5.38 % 10.64 %
Pre-Tax Margin (Q3 TTM) -830.81 % 3.29 % 5.87 % 11.58 %
Pre-Tax Margin 5 Yr. Avg. - 20 % 8.83 % 19.12 %
Net Margin (Q3 MRQ) -2185.01 % 4.63 % 4.3 % 8.42 %
Net Margin (Q3 TTM) -829.8 % 1.13 % 4.5 % 9.32 %
Net Margin 5 Yr. Avg. - 13.65 % 7.02 % 15.07 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) -1541.63 % 6.44 % 7.14 % 8.03 %
Free Cash Flow Margin (Q3 TTM) -684.1 % - - -
Free Cash Flow Margin 5 Yr. Avg.